Viemed Healthcare, Inc. beat EPS estimates 54% of the time across 13 reported quarters (7 beats, 6 misses), averaging +6.5% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $0.10 | $0.07 | -30.0% | Miss | |
| Q1 FY26 | $0.09 | $0.06 | -33.3% | Miss | |
| Q4 FY25 | $0.12 | $0.14 | +16.7% | Beat | |
| Q3 FY25 | not reported | $0.09 | not reported | not reported | |
| Q2 FY25 | not reported | $0.08 | not reported | not reported | |
| Q1 FY25 | not reported | $0.06 | not reported | not reported | |
| Q4 FY24 | not reported | $0.10 | not reported | not reported | |
| Q3 FY24 | not reported | $0.10 | not reported | not reported | |
| Q2 FY24 | not reported | $0.04 | not reported | not reported | |
| Q1 FY24 | not reported | $0.04 | not reported | not reported | |
| Q4 FY23 | not reported | $0.09 | not reported | not reported | |
| Q3 FY23 | not reported | $0.07 | not reported | not reported |
Back to VMD overview · VMD holders · VMD KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.